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A BST R A C T  
This thesis is about Herpes Zoster, a common disease that touches most of people at 
all ages. In this paper, we are going to give a general view of the specific disease and in 
 
Epidemiological aspects of Herpes Zoster are analyzed as also the adverse reactions 
on the human. Furthermore, we refer to the risk factors that lead to the disease. 
Ways that help to prevent and manage the complications of Herpes Zoster, ways to 
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          The virus is a microorganism and parasitic pathogen that causes various 
infectious diseases in plants, animals and people. With the passage of time made possible 
the observation of the viruses from the electric microscope and so observed that the virus 
has RNA or DNA and they multiply in living cells (against host cell) because they lack 
enzyme system. The virus is inactive when is outside of the cell and the size of the virus 
varies. The dermatitis may be due to the infectious viruses causing rashes during 
childhood, such as measles and chickenpox. 
Specific, one known virus is the Herpes virus (herpes simplex) known also as Human 
Herpes Virus 1 belongs to a class of virus that can cause the Varicella Zoster Virus (VZV) 
and Herpes zoster (Konstantinos I. Kanitakis, 2005).  
The Herpes zoster virus has 130-170nm and is pathogenic for the skin, eyes, nervous 
system and mucous membranes. There are two types of Herpes virus, the Herpes virus 1 
that causes the facial herpes and the Herpes virus 2 that causes the herpes genital. This 
diploma analyzed the herpes virus 1. 
Herpes virus 1 or Herpes zoster is caused by the chickenpox virus, and can be 
considered as a painful disease, and there is a formation of rashes, which then disappear. 
Every person who has had chickenpox can develop shingles at some point in his life. 
Individuals who get one of the two viruses (chickenpox or herpes zoster) have immunity 
against the other and this called cross-immunity (Konstantinos I. Kanitakis, 2005).  
For the treatment of herpes zoster are used antiviral (virostatics) drugs that are 
nucleoside or nucleotide analogues. There are used drugs like Acyclovir (Zovirax) or 
 and some more combinations of drugs 
that analyzed later on.  
2. Definition of H erpes zoster 
name cingulus and from the Greek language zostrix that means belt or girdle (Ramos T. 
A., et al 2006).  Herpes zoster or shingles is a lupus vesicular skin disease and is a painful 
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situation because blisters are created across the nerves (see Figure 1). Herpes is directly 
related to the varicella virus because this is caused by. The varicella virus usually occurs 
in childhood with symptoms such as high fever, characteristic rashes, has the ability to 
remains dormant for decades in the nerve cells of the sensory dorsal root ganglion and can 
be reactivated when finding opportunity. The cause of this reactivation is unknown but 
usually is related with a transient failure of the immune system and the age. The greater 
age one has the greater chances has to develop blisters. Herpes zoster usually affects the 
lumbosacral, the cervical, and the cranial dermatomes (Buchbinder SP., et al 1992). The 
chickenpox virus transmitted through the respiratory tract and can be transferred to and 
infect other people. The incubation time is 14 days and after this period the infected cells 
penetrate the capillaries, reach the skin that infect it and then the characteristics rashes 
shown (Arvin A.M., 1996).  
The rashes appear for few days and the patient may feel pain even no rashes are 
shown. This is known as zoster sine herpete (Gilden DH., et al 1994). In 
immunocompromised patient, the dermatomal distribution of the virus is low and the total 
duration of the disease is usually 7-10 days, but the skin to return to its normal state may 
need 2-4 weeks. In elderly, the duration is 6 weeks maybe and more. The pain, however, 
can remain for years and is one of the complications of zoster that is called Postherpetic 
neuralgia (PHN) and occurs more in elderly> 50 years old (Taylor LP., et al 2002). 
Initially, the rash begins as small red dots (plaques) on the face, scalp and upper arms and 
legs. After 10  12 hours these red dots become into small blisters and pustules followed 
by the formation of scabs.  
The localization of herpes zoster in dermatomes requires special attention because 
herpes zoster with dermatological distribution is an infection of the healthy adult and 
there is a high risk of virus reactivation in the immunosuppressed patients (HI, leukemia). 
For this reason, caution should be given and look clinically the patient but also to ask for 
the personal of medical history. 
 Shingles is a self-limiting disease and can be treating with antiviral agents 
(Acyclovir, famciclovir and valaciclovir) that are used in the whole Europe. These drugs 
can be given orally in the first 48-72 hours of the appearance of the rash so to decrease the 
symptoms like pain. These drugs blocks virus replication and inhibit its spread. For the 
pain, can be used also analgesics or local anesthetics (Dworkin RH., et al 2003).   






F igure 1: Painful shingles are created across the nerves 
Source: http://www.aidsmeds.com/articles/Shingles_6798.shtml, accessed at 
25.06.2013 
3. Pathophysiology of Herpes zoster 
The Herpes Zoster is caused by the chickenpox (Varicella zoster virus-VZV) 
comprising from a double-stranded DNA virus and is a contagious virus. The primary 
infection of chickenpox appears during the childhood and then the virus entry and remains 
dormant in the sensory dorsal root ganglia for decades (Strauss SE., 1994). Therefore, 
herpes zoster occurs only in persons that have been infected in the past by the chickenpox 
virus. The cause of the reactivation is unknown but usually is due to low immune system, 
low cell-mediated immunity that are responsible for the activation of T-lymphocytes, 
stress, age, fatigue, trauma and some other factors (Thomas SL., et al 2004). The varicella 
zoster virus after reactivation travels in the nerve cells and then the intact virions are able 
to penetrate the epidermis because travel through the axons of the skin. Therefore, virions 
cause skin infection by forming blisters and pain (Post herpetic neuralgia-PHN). This pain 
may appear some time to years. After studies performed have shown that the PHN destroy 
with the passage of time the nerves of the dorsal root ganglia and of spinal cord (Bowsher 
D., 1995). 
4. C linical manifestation of H erpes zoster 
Herpes zoster is a dermatomal disease and most often, the characteristic rashes occur 
at the lumbar or thoracic nerve part or in the chest spinal nerves (see Figure 2). The signs 
and the symptoms occur on the one side of the body and usually in one dermatome. 
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Herpes commonly begins with the prodrome phase and this is the first stage of symptoms 
before the rash onset and usually lasts 3 days but sometimes can lasts 2 weeks. During 
this prodromal phase, constitutional symptoms like burning, itching, hyperesthesia or 
pruritus can appear three or more weeks before rash onset in the dermatomes, which will 
become affected (Stankus SJ., et al 2000). Usually, during the appearance of this 
prodrome there are chances to confuse the symptoms of Herpes zoster with 
gastrointestinal disorders, cardiac problems, gynecological and various others.  
After the prodromal phase, the characteristic rash of Herpes zoster, localized pain and 
an erythematous vesicular rash is developed which followed by dermatomal distribution. 
The most characteristic symptoms of the rash are the headache, the photosensitivity but 
the most important symptom is the pain, which described like burning, stabbing and can 
also lead to the most important complication the post-herpetic neuralgia (Goh L., et al 
1997). Usually the rash affects the ophthalmic dermatome in the trigeminal nerve, which 
may lead to blindness. Shingles form blisters approximately in 7-10 days but to return to 
its normal phase may need 2-4 weeks (Wilson JF., 2011). 
 
F igure 2: The characteristic rash of Herpes zoster 
     Source: http://www.drugs.com/cg/herpes-zoster.html , accessed at 28.06.2013 
5. Diagnosis of H erpes zoster 
  Herpes zoster can be diagnosed clinically because is enough for the healthcare 
providers to understand it when there are developed skin lesions. Patient with herpes 
zoster will have localized pain, which appear a few days to weeks and a characteristic 
erythematous vesicular rash that leads to a dermatomal allocation. First red spots are 
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formed which then are converting to small vesicles. The inflammations of the skin can be 
motley or accumulated. Most patients describe the zoster with a burning sensation or 
dysesthesias. 
  In cases where there is absence of the rash or in immunosuppressed patients in 
which the pattern of the blisters and location of the rash are atypical there are laboratory 
and physical methods for diagnosis (Beers, et al 2004):  
 Tzanck test: In this test, a smear is taken from the blister and the cells that have 
been infected with herpes will be sizable and will have nuclei. 
 Viral culture of the rashes: Because the virus is growing slowly is not used very 
frequent for practical objectives. 
 Immunoglobulin (IgM) antibody test: In this situation IgM antibody appears in the 
blood only when the herpes virus is reactivated (Arvin AM., 1996) 
 Direct immunofluorescent test: Is rapid and low cost test 
 PCR test 
 Monoclonal antibody test 
6. Causes and risk factors 
VZV consists of a double-stranded deoxyribonucleic acid and is infectious. So only 
those who have been infected with chickenpox can develop herpes zoster sometime in 
their life. This is happening because the chickenpox virus remains dormant for decades in 
the sensory dorsal ganglia and can be reactivated when finding opportunity. Investigations 
have shown that the one-third of the population will show herpes zoster especially those 
with age older than 60 years (Harpaz R., et al 2008).   
These that are in higher risk to develop herpes zoster are the immunosuppressed 
people like those with HIV, with malignancies and reduced immune system. Some recent 
trials have demonstrated that the existence of herpes zoster is increasing but we cannot 
give the explanation. However, the sure is that after decades, the incidence of HZ will 
change because science is constantly evolving and there will be changes in the therapy of 
malignant, of HIV and possibly because of the result of childhood vaccination (Seward J., 
2000).  
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    Shingles occur only in those persons that had been infected in the past with chickenpox. 
There are specific risk factors that involved and increase the appearance of herpes zoster: 
6.1 Infection with V Z V 
The primary factor and the most important role for the appearance of Herpes zoster is 
the re-activation of Varicella zoster virus, which is in latent phase. The first infection with 
the VZV appears as chickenpox and since then as herpes (shingles). The age at which the 
person experienced chickenpox associated with the age at which zoster occurs. However, 
the people at risk for pediatric zoster are those who in the early childhood gain an 
intrauterine infection with VZV (Kilgore PE., et al 2003 and Brunell PA., et al 1981). 
6.2 Aging 
The aging is the most basic and the most important risk factor for the appearance of 
herpes zoster. First of all after many investigations that have been conducted around the 
world for the relationship between the age and the chickenpox have shown that the 
incidence of herpes zoster is directly connected with the age. Specific studies showed that 
the older age one has, the greater chances to develop herpes zoster. The sure is that the 
total number of cases with herpes zoster will rise because the generation of the babies 
getting old. The older persons or the immunosuppressed patients are at high risk to 
develop herpes zoster because the cell-mediated immunity activates less T-lymphocyte, 
which secretes cytokines. (Hope-Simpson RE., 1965 and Thomas SL., et al 2004).  
   The age also has a direct relationship with the development of Post herpetic neuralgia 
(PHN). The risk of PHN increases after the age of 50 years old. This relationship has 
proven in a survey was done and the results showed that people >50 years old have a 
percentage 80-85% more chances to develop Post herpetic neuralgia (Choo PW., et al 
1997).   
6.3 Immunosuppressant individuals and emotional stress 
People suffering from HIV, AIDS and bone or marrow transplantations are at risk to 
develop herpes zoster. Also at risk are those with childhood cancer because all those have 
and lymphoma are at risk. Some more risk factors are the exhibition to immunotoxins and 
the psychological stress, which will result in appearance of herpes after 6 months of the 
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event (Gatti A., et al 2010). Immunosuppressed have 20 times more chances to develop 
herpes than immunocompetent patients.  
6.4 Certain drugs 
Some certain drugs decrease the immune system and contribute in the 
development of shingles. Such drugs are used from patients with organ transplantations, 
HIV, diabetes, lupus erythematosus and others. Some of these drugs are the infliximab, 
cyclosporine, ezathioprine, adalimumab. 
6.5 F emale sex 
Studies reported that the incidence of herpes zoster in women is more common than in 
the risk factors together there is a percentage of 35% for women appearance and specific 
for those with age over 50 years. In addition, the developing of PHN is more in women 
than in men. Of course, others believe that sex does not play a role in the incidence of 
herpes zoster (Thomas SL., et al 2004).  
6.6 E thnicity 
Some investigations made in US support that the white race develops more often 
herpes zoster than the black one (Tseng HF., et al 2011). 
6.7 Seasons 
Studies have been reported that the reactivation of VZV is more common in the 
summer and this because of the ultraviolet irradiation and because the skin is exposed. 
However, some other scholars believe that there is no relationship (Arvin AM., 1996). 
7. Complications of H erpes zoster 
   Herpes zoster is a self-limiting disease and is caused when varicella zoster virus, which 
belongs to the alpha herpes virus of human, reactivated (Abendroth A., et al 2010). 
Clinically this reactivation is important because of the various complications that causes. 
These complications can affect the neurological, the ocular and others systems (Volpi A., 
2007). For the good management of the complications the treatment must begin quickly in 
order to decrease the severity. Some of these complications are: 
	   15	  
7.1 Pain 
Herpes zoster when is active creates a discomfort pain which is the primary and the 
most common complication. The pain can occur with three ways: 
- It can be a constant pain 
- It can be periodic 
- It can occur like electric shock-spasm 
The pain can be defined also as allodynia or hyperalgesia, two complications that are 
more potent. The feeling of pain change with the temperature and at night is more 
severe. This complication is important because affects everyday life of the patient and 
the quality of life. However, pain does not appear on a daily basis (James WD., et al 
2006). 
7.2 Post herpetic neuralgia (PH N) 
Post herpetic neuralgia occurs in older people with age older than 50 years. Is the 
most common and the most severe complication, which exists for more than one month, 
maybe for years. The pain is described as burning, gnawing and allodynia (Dworkin RH., 
et al 1996). The pain affects the nerves of the spinal cord. Do not develop all the patients 
post herpetic neuralgia. This depends from the age, gender and from the kind of the 
shingles. Sometimes if the pain is persistent and not treated effectively may lead to the 
depression of the patients (Straus SE., et al 2008). 
7.3 Secondary infection 
There are chances for bacterial infections, Staphylococcus aureus or 
Streptococcus, when the blisters did not covered and clean well. 
7.4 Ramsay Hunt syndrome 
The symptoms of this syndrome are loss of taste, vomiting, dizziness, hearing of loss, 
ringing and severe pain in the ear. This syndrome occurs when herpes affect the cranial 
nerves. This lead to facial paralysis, and rash is noticed in the ear. Facial paralysis can be 
intermittent and the loss of hearing may be total or partial (Kim JH., et al 2007). 
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7.5 E ffects on the brain 
The effects on the brain can be for example meningitis and encephalitis. In 
immunocompetent people, these complications are mild but in immunosuppressed are 
severe and may lead even to the death (Grann Jw Jr., 2002). 
7.6 O cular infection 
When herpes infect the eye, herpes zoster ophthalmicus envelop. In this case, the 
herpes affect the trigeminal nerve and shingles appear in the face. This means that the 
eyes are at high risk and when are involved the treatment is difficult. Herpes zoster also 
causes glaucoma, keratitis, retinitis (James WD., et al 2006 and Tugal-Tutkum I., et al 
2010). 
 7.7 Urinary tract infections 
The effects of herpes in the urinary tract are not so frequent but when it is happening 
cause urinary retention, hematuria and erectile dysfunction (Erol B., et al 2009). 
8. Prevent the transmission of H erpes 
Shingles can be transmitted from one patient to another through the contact with the 
fluid of the rash. The varicella zoster virus and the herpes zoster can be transmitted and 
infect even people who have never been infected in the past with chickenpox. Therefore, 
these persons can develop only chickenpox and no herpes zoster. 
Shingles can be transmitted less than varicella zoster virus. The patient should cover 
the rash because will be less dangerous and less risky to spread. In addition, should not 
scrape the rash, should keep it covered and it is necessary to wash the hands 
systematically in order to avoid the transmission of the virus. 
In order to avoid the transmission of the zoster individuals that have herpes zoster 
must avoid going to the work or in places with people so to avoid come in contact with 
sensitive persons. Individuals should be avoided at people with herpes are primarily 
pregnant women, newborns and older people. All of us should know the symptoms of 
zoster so to can dodge as people with herpes (Bolyard E.A., et al 1998).  
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9. T reatment of H erpes zoster 
The existence of an effective treatment requires a very good education of the patients 
around herpes zoster. Patients should know what is happening with herpes zoster, the 
symptoms, the risk factors and the complications. They should be prepared to face herpes 
when it will appear the chronic pain that causes and they should know how to use right 
the drugs. It is important to know that for better confrontation of pain patients should start 
the therapy in the first 24 hours.  
All the future patients with herpes must know how to protect the others from the virus 
in order to prevent the transmission. For this reason, those with active herpes should avoid 
to contact with others, especially with those that did not affected in the past with VZV, 
pregnant women, immunosuppressed people, infants and young children. Therefore, it is 
better to placed infected patients alone. 
9.1 Antiviral agents 
    Antiviral drugs reduce the healing time of the skin lesions, the acute pain, the severity 
of symptoms and the formation of new lesions (Schmader K., 1995). However, to have 
these results the patients must take the drug in the first 72 hours after the appearance of 
the rash. Also is important to know that the antiviral drugs do not affect all the patients 
with herpes zoster but more those who are older than 50 years, have severe rash or they 
have not any trunked involvement. 
   After many studies that have been conducted on whether the antiviral reduce the post 
herpetic neuralgia are contestable. However, studies have shown that acyclovir and 
valacyclovir can reduce a little the post herpetic neuralgia (Crooks RJ., et al 1991), with 
the condition that the therapy begins in the first 72 hours or better 48 hours. Because if the 
therapy starts after 72 hours there will be adverse effects in elderly like ophthalmic 
problems and severe pain. 
    In this group, there are two most known antiviral drugs, the acyclovir and the 
valacyclovir. Both of these are safe, give good benefits and reduce the risks. Some clinical 
trials shown that valacyclovir have greater efficacy and greater bioavailability after oral 
administration than acyclovir (Degreef H., 1994). 
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   It is recommended the administration of these drugs to start in the first 72 hours in order 
to avoid the formation of new vesicles and motor, ocular or neurologic complications 
(Katz J., et al 2004). The patients who still form vesicles after 7 days of antiviral therapy 
are recommended to continue for more days the therapy. However, attention must be 









F igure 3: Chemical structure of acyclovir 
Source:http://chemistry.about.com/od/factsstructures/ig/Chemical-Structures---
A/Acyclovir.htm , accessed at 08.07.2013 
 
Acyclovir is an anhydrous basis as is showing in the Figure 3. Acyclovir is an 
antiviral and the prototype drug, which is used against herpes zoster. This drug reduces 
the duration of the virus, decreases the formation of new vesicles, the pain and the time of 
healing (Huff JC., et al 1988 and McKendrick MW., et al 1986).  
The acyclovir is a nucleoside analogue and can be administered per oral or 
intravenously. Immunosuppressed patients and these which are not able to take drug 
orally, it is preferred the intravenously administration. 
According to the pharmacology, acyclovir is converted by thymidine kinase to acyclo-
guanosine monophosphate and then through phosphorylation is converted to triphosphate 
by kinases. This acyclo-guanosine triphosphate inhibit the replication of the herpes DNA 
and this completed by inhibiting the DNA polymerase, by terminating the viral DNA 
growth and by inactivating the viral DNA polymerase (American journal of Medicine, 
1982).Acyclovir general has poor oral bioavailability and the peak concentration of 
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plasma appears after 1-2 hours. The elimination half-life is about 3 hours and is excreted 
by glomerular filtration, tubular and renal secretion. 
Acyclovir is administered per oral, in the form of capsules, tablets and suspensions. 
The brand name of acyclovir is Zovirax and each capsule or tablet contains 200mg, 
400mg or 800mg and the excipients, like lactose, providone and others. 
In adults, the dosage can be 800mg, five times per day for 7-10 days. It is important 
the patient to be consistent, compliance and to start the therapy in the first 72 hours of the 
rash onset. The patient should not exceed the recommended dose because there will be 
nephrotoxic problems and adequate hydration especially in those with renal failure. In 
patients with renal failure is recommended the intravenously administration. 
Others adverse effects are the fever, headache, pain and peripheral edema. In the 
nervous system can be observed par aesthesia, ataxia, tremor, coma and psychotic 
symptoms. In addition, the adverse effects can be diarrhea, nausea, gastrointestinal tract 
complications, visual problems, alopecia, Stevens-Johnson syndrome and pruritus. In 
hepatobiliary tract and in pancreas can be observed jaundice and hepatitis. Last can be 
observed myoskeletal complications like myalgia and urogenital complications like blood 
in the urine. 
The precautions of acyclovir is that the patient must inform the doctor if he/she has 
allergies or is allergic to this specific active substance (acyclovir) or in any excipient. For 
this reason, in order to avoid any complication is important the doctor to know the 
personal medical history of each patient. When the patient is taking acyclovir is 
recommended not drinking and not driving because acyclovir can cause drowsy 
(http://www.nlm.nih.gov/medlineplus/druginfo/meds/a681045.html, accessed at 
08.07.2013). 
Is someone forgot to take a dose can take it as soon as he/she remember it and to 
continue with the next proper dose. However, in cases of over dosage, there will be 
observed the adverse effects like nausea, vomiting, headache, gastrointestinal tract 
problems and others. In order to remove the unabsorbed drug is recommended the patient 
to take charcoal. Hemodialysis is one method, which helps also to remove unabsorbed 
acyclovir in the case of overdosage, toxicity, renal failure and anusia 
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F igure 4: Chemical structure of valacyclovir 
Source: 
http://es.m.wikipedia.org/wiki/Archivo:Valacyclovir_Structural_Formulae.png, 
accessed at 08.07.2013 
 
    Valacyclovir (see Figure 4) is an antiviral drug and nucleoside analogue, which is used 
against herpes simplex 1 and 2 and chickenpox. The brand name of valacyclovir is 
Valtrex and is used against shingles, genital herpes, herpes zoster and cold sores. 
Valacyclovir has long bioavailability after oral administration than acyclovir and the 
action of valacyclovir lasts longer. 
Mechanism of action: 
    Valacyclovir hydrochloride is converted to acyclovir by esterases and has antiviral 
activity against herpes zoster 1 and 2 and against chickenpox. Then the thymidine kinase, 
which is more active than cellular thymidine kinase, converts the acyclovir to acyclovir 
monophosphate which then is converted to triphosphate by cellular enzymes. Acyclovir 
triphosphate inhibits the replication of the viral DNA of herpes and this completed by 
inhibiting the DNA polymerase, by terminating the viral DNA growth and by inactivating 












F igure 5: The mechanism of action of valacyclovir. Primary is converted to 
acyclovir by esterases, then to acyclovir monophosphate by thymidine kinase and 
final to acyclovir triphospate, which inhibits the replication of the viral DNA of 
herpes. 
Source:	  http://www.medscriptspharmacy.com/valtrex.htm, accessed at 08.07.2013 
 
     Valacyclovir is in the form of caplets, which are blue and administered per oral before 
or after food. Each caplet contains 500mn or 1gr of the active substance valacyclovir and 
the excipients like dioxide, providone, colloidal silicon dioxide and others. The dosage for 
the orofacial herpes is 2gr of valacyclovir, two times daily for only one day because of the 
high dose. For the treatment of herpes zoster the dosage of valacyclovir is 1gr, three times 
daily for 7 days.  
   The therapy is recommended to start in the first 48 hours of the rash onset. The 
treatment of the intermittent herpes is the usage of 500mg valacyclovir, two times daily 
for 5 days. General careful should be given in patients with renal failure and the dosage is 
recommended to reduce. Valacyclovir in
probenecid. These interactions lead to change the action of the main drug valacyclovir and 
to cause several adverse effects. In addition, this can lead to an increase of valacyclovir 
concentration in the blood.  
    Attention should be given when the doctor makes diagnosis and prescribed medicines 
because the patient is important to inform the doctor if he/she has allergy in some active 
substances or excipients.  For this reason is basic the doctor to know the personal medical 
history of each patient. Valacyclovir because can cause drowsy the patient should avoid to 
drive and not to drink. Also is recommended the patient to avoid the close contact with 
others because the herpes is transmitted easy.  
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For this reason, avoid kissing the others and especially the immunosuppressed patients 
(http://www.medicinenet.com/valacyclovir/article.htm, accessed at 09.07.2013).  
    If a woman is pregnant, the usage of valacyclovir should be used in special cases. 
However, studies have not accurate results about how much the uses of acyclovir or 
valacyclovir affect the pregnant woman. 
    Some of the adverse effects of valacyclovir are the headache, nausea, vomiting and 
pain in the lower back and in stomach. The most serious adverse effect is the thrombotic 
thrombocytopenic purpurea (TTP), which is observed in HIV patients, in patients with 
bone or renal transplantations. The death can be caused from thrombotic 
thrombocytopenic purpurea and when there are problems with the kidneys or the 
medication affects the cells of the blood. In addition, an important complication is the 
renal impairment, which is related to patients with renal disease. This is caused because 
some patients take more dose than the recommended. Attention should be given in elderly 
patients in which should be given low dosages in order to avoid renal impairment. 
Although can be observed complications in the central nervous system like mood 
changes, hallucinations, confusion and problems in concentrating. In cases of over dosage 
unabsorbed valacyclovir can be observed in renal tubules when the solubility of the 
intratubular fluid is higher. The method to remove the precipitated valacyclovir is the 
hemodialysis (http://www.drugs.com/sfx/valacyclovir-side-effects.html, accessed at 
09.07.2013). 
Patients with ocular herpes zoster should be treated immediately because the 
infection of trigeminal nerve by herpes can leads to blindness, iritis and keratopathy 
especially in elderly 50 years old (Cobo M., et al 1987). Antiviral therapy should be 
administered in these patients like acyclovir or valacyclovir and may be combined with 
corticosteroids. It is important to reduce the mortality and morbidity of herpes and for this 
reason is necessary a safe treatment to start early from the first symptoms. Usually the 
patients develop once herpes in their life after the activation on chickenpox, of the 
varicella zoster virus. 
 
 
	   23	  
9.2 Corticosteroids 
Corticosteroids are administered orally and help to decrease the pain, the post herpetic 
neuralgia, the process of the clinical treatment, the complications and to procure 
analgesia. 
The most known corticosteroid that is used for the treatment of herpes is the 
prednisolone (see Figure 6). This can be administered together with acyclovir so to 
decrease the feeling of pain and this is achieved because decrease the inflammation of the 
affected nerves (Whitley RJ., et al 1996). Some studies that have been conducted have 
shown that the usage of prednisolone can prevent the post herpetic neuralgia but some 
other studies have shown that there is no relationship (Whitley RJ., et al 1996 and Esmann 
V., et al 1982). The dosage is 40mg or 60m once a day, usually in the morning, for 7-10 
days. 
Some studies examined the evaluation of the usage of corticosteroids together with 
acyclovir and he results were that this combination succeeds the reduction of neuritis 
(Whitley RJ., et al 1996 and Wood MJ., et al 1998). Also another study show that the 
combination of injected steroids, local anesthetics, antivirals and analgesics reduce the 
pain which is caused by herpes for 1 month (van Wijck AJ.,et al 2006). 
In severe cases of herpes pain, in cases of facial paralysis and complications in the 





F igure 6: Chemical structure of prednisolone 
Source: http://www.drugs.com/pro/prednisolone-tablets.html , accessed at 10.07.2013 
The patients who use drugs that decrease the immune system are more sensitive than 
the immunocompetent. Herpes zoster can be a serious problem and can cause the death in 
immunosuppressant patients and mainly in elderly patients. It is important in elderly and 
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persons who had not been infected by chickenpox to not exposure in the virus and to 
caution by infected patients. The varicella zoster immune globulin can prevent and protect 
those who exposed to chickenpox. The corticosteroids heal the rashes of the herpes but 
the prolonged use of corticosteroids is not recommended because can cause glaucoma, 
damage to the nerves of the eye and other diseases. The immunosuppressant patients who 
use corticosteroids should avoid coming in contact with patients that have chickenpox or 
zoster. In cases that have been exposed must start the medical treatment as soon as 
possible. Patients with hypothyroidism or these patients that have ocular herpes the 
corticosteroids should be used with moderation and caution 
(http://www.drugs.com/pro/prednisolone-tablets.html, accessed at 10.07.2013). 
Some adverse effects of corticosteroids and prednisolone can be musculoskeletal like 
loss of muscle mass, weak muscles, osteoarthritis and neurological like vertigo, nausea, 
vomiting and headache. Also in gastrointestinal tract can be observed some complications 
like pancreatitis and peptic ulcer.  
According to the pharmacology prednisolone is agonist of alpha and beta 
glucocorticoid receptor and can reduce the inflammation. This anti-inflammatory action 
achieved by inhibiting the transcription of COX-2, T-cells and cytokines. Also inhibits the 
phospholipase A2 and with the cytotoxic actions reduce the mediated immune reactions 
of cells and antibodies. 
9.3 Analgesics 
Patients with limited skin involvement can have severe pain and for this reason is 
important to check it. If the diagnosis is made early, there are many possibilities to 
decrease the risk for post herpetic neuralgia except the acute pain. Therefore, the quality 
of patient life will be better especially in elderly, which have more possibilities to develop 
post herpetic neuralgia. Analgesics are administered per oral within 72 hours of the rash 
onset. Analgesics, for example ibuprofen (see Figure 7) and naproxen (see Figure 8) may 
be administered in patients during herpes with acute and chronic neuralgic pain. Also 
together with analgesics can be added anticonvulsant agents for example gabapentin, or 
the tricyclic antidepressants like amitriptyline, so to reduce the prevalence and severity of 
pain. Many analgesics can be used for the treatment of herpes: 
 




F igure 7: Chemical structure of ibuprofen 
Source:	   http://www.galinos.gr/web/drugs/main/substances/ibuprofen, accessed at 
11.07.2013 
and fever. Ibuprofen inhibits the enzyme-COX, which converts arachidonic acid to 
prostaglandin H2. Also can reduce the pain but simultaneously can cause several adverse 
effects like diarrhea, hypertension, heart failure, renal impairment and hyperkalemia 
(Rossi S., 2004) 
The duration of ibuprofen is around 4-8 hours. Ibuprofen is in the form of tablets and 
the maximum amount for adults is 3.200 mg. But general the doses for all patients 






F igure 8: Chemical structure of naproxen 
Source: http://www.medicineonline.com/drugs/n/4266/NAPROXEN-DELAYED-
RELEASE-TABLETS.html, accessed at 11.07.2013 
body by inhibiting the enzymes COX-1 and COX-2. Naproxen is used for several diseases 
like fever, arthritis, gout, tendinitis, migraine and dysmenorrhoea (French L., 2005). 
Patients that have allergy to this must not use this active substance. There are many risks 
when someone takes naproxen, like heart attack, chest pain, weakness muscles, vision 
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problems, shortness of breath and many others. For this reason is important the patient to 
inform the doctor if he/she has liver disease, heart disease, history of heart attack, high 
blood pressure and blood clotting. 
Also can be used the capsaicin that contains chili pepper and can treat the post 
herpetic neuralgia (Lee PJ., et al 1998). The capsaicin when is putted on the skin in the 
affected nerves three times daily, release the substance P that is a neuropeptide and can 
relief the pain. Patches also can be used that contain lidocaine in order to reduce post 
herpetic neuralgia.  
10. T reatment of herpes zoster and Postherpetic neuralgia 
   Postherpetic neuralgia is pain in the nerves because of varicella zoster virus. Usually the 
pain occurs in one dermatome in which then is developing herpes zoster. This pain may 
be appear for months even and years and is more common in elderly older than 50 years. 
These that are at risk are the immunosuppressant patients, people suffering from HIV, 
AIDS and transplantations. Also at risk are these with cancer, with Hodgkin disease, the 
female sex and the white race.  
  The symptoms for postherpetic neuralgia are the pain, which is severe, appears for more 
than 3 months, and is likened as burning. Post herpetic neuralgia is a difficult situation as 
well as and the treatment is. First, the patient with PHN should be addressed to the 
physician, to the doctor in order to administer him/her one drug of these groups: 




F igure 9: General chemical structure of tricyclic antidepressants  
Source: http://en.wikipedia.org/wiki/Tricyclic_antidepressant, accessed at 12.07.2013 
Tricyclic antidepressants (TCA) are heterocyclic and contain three rings (see 
Figure 9). Similar to these are the tetracyclic antidepressants. In TCA belong the 
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selective-serotonin-reuptake inhibitors (SSRI), the norepinephrine reuptake inhibitors 
(NRI) and the serotonin-norepinephrine-reuptake inhibitors (SNRI) antideprassants.  
The tricyclic antidepressant except their benefit in the treatment of postherpetic 
neuralgia is used also for the treatment of dysthymia, anorexia, panic disorder, mood 
disorder and in many others. The tricyclic antidepressants can reduce the postherpetic 
neuralgia by inhibiting the serotonin and norepinephrine reuptake or by blocking the 
sodium channels (Ardid D., et al 1992). Some tricyclic antidepressant drugs are 
nortriptyline, desipramine, imipramine and amitriptyline.  
For better results is recommended to start the use of TCA after one year of the 
symptoms appearance, but the time in order to understand the effectiveness of these drugs 
takes weeks (MacFarlane BV., et al 1997). The tricyclic antidepressants have many side 
effects, like dry mouth, urinary retention, akathisia, tachycardia, muscle weakness and 
especially in patients older than 50 years old (Gelder, et al 2005). 
Tricyclic antidepressants interact with cimetidine, antipsychotics, fluoxetine and 
calcium channel blockers, so with these drugs that inhibit cytochrome P450. This happens 
because the metabolism of TCA takes place in cytochrome P450. Usually for the therapy 
of post herpetic neuralgia in elderly nortriptyline is used and the dosage is 10-25mg in the 
night for two weeks or can be administered for one day only in higher doses, 75-150mg. 
Selective-norepinephrine-reuptake inhibitors antidepressants like venlafaxine or 
duloxetine are used for the treatment of postherpetic neuralgia, for diabetic neuropathy, 
for social anxiety disorder and in many ither diseases. The dosage of SNRI 
antidepressants for the relief of postherpetic neuralgia is 60-120mg, which is taking 
separated into two doses (Cymbalta, 2011). 
10.2 Opioids 
Opioids are psychoactive and bind to opioid receptors. These drugs are used to the 
treatment of pain like post herpetic neuralgia, cancer pain and rheumatoid arthritis 
(Alexander GC., et al 2012). Also is used in patients in whom the tricyclic antidepressants 
have no effect. Opioids administered per oral or through patches. The usage of opioids is 
usually the second choice for the treatment of postherpetic neuralgia. There are many 
adverse effects like vomiting, dry mouth, constipation, hypothermia, orthostatic 
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hypotension and hallucinations (Doyle D., et al 2004). Caution should be given in this 
group because one of the most serious adverse effect is the tolerance and when is happens 
in order to alleviate it zinc, NMDA antagonists or calcium-channel blockers is used 
(Kollars JP., et al 2005).  
because decrease the acute pain in patients with herpes zoster through the several 
mechanisms of actions in the Central nervous system and in Peripheral nervous system. 
Analgesic opioids usually used together with weak analgesics like acetaminophen or with 
non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. However, these 
combinations have not been studied if there are effective in patients with HZ or chronic 
neuropathic pain. The most know drug that is used for the treatment of postherpetic 
neuralgia is the: 
- Oxycodone 
This drug is narcotic opioid and is used to control the severe pain especially in 
patients with herpes zoster. Oxycodone should not be given in the patients that have a 
history of drug addiction and is recommended do not drink during the therapy with 
oxycodone. There are several side effects like dyspnea, respiratory arrest, nausea, 
constipation, anxiety, pain in the abdominal, bradycardia even and death. Also the risk of 
using oxycodone is that the patient has many possibilities to be addicted to this drug 
(http://www.drugs.com/dosage/oxycodone.html, accessed at 13.07.2013). 
Oxycodone is administered per oral 10-30mg six times daily. The mechanism of 
-opioid receptor but has effects similar to morphine 
-receptor and this because the metabolism of oxycodone takes place in the 
liver (Kalso E, 2007) 
- Tramadol 
Tramadol can relief the pain, and it has properties similar to opioids and is a weak 
agonist -opioid receptor. Tramadol inhibit serotonin and nor-epinephrine release and 
the maximum dose is 400mg/d. Not severe adverse effects can cause in gastrointestinal 
tract (Boureau F., et al 2003). 
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- Tapentadol 
Also can relief the pain, is a weak agonist -opioid receptor and inhibits more the 
release of nor-epinephrine. The maximum dose of tapentadol is 600mg/d. 
10.3 Anticonvulsants 
Anticonvulsant or antiepileptic drugs are used for the treatment of epileptic seizures 
but also for the therapy of neuropathic pain and postherpetic neuralgia. The 
anticonvulsant drugs suppress the excited nerves that are responsible for the feeling of 
pain and for postherpetic neuralgia. The drugs that are used more usually are the 
gabapentin and the pregabalin. Studies have shown that are effective to treat PHN 
(Rowbotham M, et al 1998).  
- Gabapentin 
Gabapentin is the most common drug used for the treatment of postherpetic neuralgia. 
The dosage, which should be administered, is 400mg, three times daily for few weeks. 
Gapa
postherpetic neuralgia. This drug can be administered together with antiviral drugs, like 
acyclovir or valacyclovir, in order to decrease the acute pain. 
In the most patients have noted no serious adverse effects and for this the patients can 
take larger amount of dose. This does not mean that no one will do not have adverse 
effects for example memory disturbances, liver toxicity, dizziness, agitation, stomach pain 
and many other complications. However, in elderly the usage of gabapentin is safer than 
tricyclic antidepressants (MacFarlane BV., et al 1997). 
- Pregabalin 
Pregabalin is similar to gabapentin and the dosage ranges between 150-300mg per 
day. The dose depends on the tolerance of the body and how it response. Pregabalin can 
be used in combination with analgesics, antivirals or antidepressants because in order to 
treat the postherpetic neuralgia requires several approaches (http://www.anesthesia-
analgesia.org/content/105/6/1805.full.pdf+html, accessed at 06.07.2013). 
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10.4   Patches  
- Lidocaine 
Lidocaine is anesthetic drug and is used for the treatment and relief of postherpetic 
neuralgia. There are small patches placed on the skin in the affected area. This patch has 
low adverse effects and can be used together with other oral medications. Lidocaine has 
the possibility to bilge into the skin and is recommended as the first choice for the 
treatment of postherpetic neuralgia (Kanazi GE., et al 2000). 
- Capsaicine 
Capsaicine contain chilli pepper, which can reduce the nerve pain caused by 
postherpetic neuralgia. Capsaicine can be found in the form of patch and cream, but 
studies have shown that cream is not so effective. It is preferred in the form of patch 
because contains higher amount of capsaicine than cream. It is recommended the patient 
to use capsaicine patch after the blisters have dried. In addition, the patients can apply 
topical aspirin, which have been cut off in acetone (Kanazi GE., et al 2000). 
11. Vaccination 
Herpes zoster is caused by varicella zoster virus, which remains dormant for 
decades in dorsal root ganglia and can be reactivated when finding opportunity. The most 
important complication is the postherpetic neuralgia, which affects the elderly, especially 
people older than 60 years. The greater age one has, the greater chances have to develop 
herpes and postherpetic neuralgia. For this reason patient should do the vaccine, which 
protect him/her from herpes and PHN (Oxman MN., et al 2005). 
- Who should receive the vaccine? 
years old is recommended to receive it in order to prevent postherpetic neuralgia 
(McKendrick MV., et al 1989 and Alper BS., et al 2000). The greater age one has, the 
greater chances have to develop PHN and herpes zoster. This vaccine is used against 
herpes zoster, not against herpes virus and is used for protection and not for treatment. 
Zostavax can reduce the postherpetic neuralgia for about 50% in patients older than 60 
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years old and the duration of action of the vaccine is for about 4 years and more (Oxman 
MN., et al 2005). 
Zostavax is important for patients older than 60 years even though did not have 
developed chickenpox in the past. FDA authorizes this vaccine and it is necessary to 
receive it when the patient does not have any shingle. Zostavax is administered in a single 
dose by injection usually in the arm subcutaneously (Mitka M., 2006 and Merck & Co, 
2011). 
The Zostavax should not be administered in patients with allergy to gelatin and to 
neomycin because are contained in the vaccine. For this is important the patient to inform 
the doctor about any allergy may have. In addition, the immunosuppressant patients with 
HIV, AIDS and those who do chemotherapy in order to treat cancer should avoid 
receiving it. Although should not be administered in patients which are using drugs that 
reduce the immune system, as for example the steroids. Last patients with leukemia, 
pregnant women or expectant pregnant women must avoid receiving it. 
 
- Does the vaccine cause serious complications? 
 
Zostavax does not cause any serious complication. The most usual complications 
are the itching and the redness at the site of injection, swelling and headache. The people 
who received the vaccine Zostavax can come in contact with pregnant women, babies and 
patients with reduced immune system and this is possible because until now there are no 
documents to show the transport of chickenpox from people who receive the vaccine. 
12. Homeopathic treatment for H erpes zoster 
 
First of all the word homeopathy takes its name from the Greek language from the 
 
suffer. Homeopathy is a system of remedy, which is non-toxic. Is a philosophy which 
supports that the patients can be treated by himself, that the body can be treated itself by 
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its nature. Homeopathy supports that the symptoms will occur in the patients who take 
large amount of a substance in order to treat these symptoms can take small amount of the 
same substance.  
 
In this remedy the homeopath use only plants and natural products in order to treat the 
disease. Homeopathy is used for several diseases like osteoarthritis, cancer, constipation, 
headache, insomnia, diabetes and in many other diseases. The amounts that are used are 
diluted and can be used by anyone even the elderly, the pregnant and the babies 
(http://www.webmd.com/balance/guide/homeopathy-topic-overview, accessed at 
26.06.2013). 
   
Herpes zoster causes blisters along the nerves and is a painful situation. First fever and 
discomfort shown and then blisters appear at the one side of the body, like the back, the 
abdomen and the face. Except the conventional therapy which analyzed above, very 
helpful is and the homeopathic treatment. Homeopathic therapy helps to relief the pain 
and to recovers the skin. Some examples are: 
- Arsenicum album 
 
Herpes usually affect the face, the lips and the eruptions getting worse in the exposure 
to the cold and after midnight. Patient with the feeling of warmth gets better but the mood 
changes constantly. The patient usually fells anxiety, depressed and irritable. So 
arsenicum album is recommended (http://www.truestarhealth.com/Notes/2257003.html, 
accessed at 26.06.2013).  
- Clematix 
Blisters, redness, itching, burning and the bad feeling when the patient washes her 
face with cold water are some symptoms exhorting the usage of clematix. This one can be 
used also by those that have genitor-urinary problems 
(http://www.truestarhealth.com/Notes/2257003.html, accessed at 26.06.2013). 
- Graphites 
Mainly obese women that have herpes use this drug. Also it is used by patients, which 
appear blisters in the one side of the body, in the spine and by those that have intense 
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itching and cannot come in contact with clothes or any foreign matter 
(http://health.hpathy.com/herpes-zoster-symptoms-treatment-cure.asp, accessed at 
26.06.2013). 
- Ranunculus bulbosus 
This is used mainly when shingles appear at the back or on the chest (ribcage), over 
the fingers and then to the whole body. This is very painful situation because it is not so 
pleasant to wear clothes or the contact with something else 
(http://www.truestarhealth.com/Notes/2257003.html, accessed at 26.06.2013). 
- Rhus toxicodendron 
This is recommended when rash appears with the form of many red and small blisters 
that are itchy and are comforted with the usage of rhus toxicodendron and the usage of hot 
compresses (http://www.truestarhealth.com/Notes/2257003.html, accessed at 26.06.2013). 
13. H erpes diet information 
 
     Persons who have been infected with varicella zoster virus, this virus will remain 
dormant in the dorsal root ganglia forever. These persons will develop herpes zoster 
sometime in their life with the characteristic blisters on the one side of the body. The risk 
to develop someone herpes increases with the older age and if someone is 
immunosuppressant. For this reason in order to prevent herpes zoster there are some 
foods, which the patient should consume. 
 
- What foods the patient should enjoy? 
 
The patient should add to his/her nutritional program foods rich in vitamins like 
vegetables and fruits. Fruits rich in vitamin A, which promote and help in the healing of 
the skin are the eggs, the fish, the mangoes and papaya. In addition, the onions, the 
oranges, the paprika and the apricots are good choice because are rich in vitamin C that 
also helps to the healing of the skin and increase the immune system.  
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Very good choice to consume the patient is the lysine and this because attacks the 
arginine, which promote the herpes virus replication. So the patient should consume 
chicken, beef, parmesan cheese and seafood. It is recommended the consumption of 
500/1000mg lysine about three times daily. Moreover, the patient should add in the 
nutritional program foods that contain Vitamin B12 and zinc because are fighting herpes 
zoster. Vitamin B12 found in the milk and blue cheese.  
 
- What foods the patient should avoid? 
 
The patient in order to antagonize herpes zoster should avoid foods high in fats and 
this because such foods cause changes in emotional mood, which is risk for herpes zoster. 
Foods rich in oils, fats, carbohydrates and sugar contain low amounts of vitamins and so 
the patient should avoid consuming. It is important to replace these foods with fruits or 
with foods, which mentioned above. Also prohibited the consumption of alcohol because 
is depressant as well as prohibited the consumption of cigarettes. White flour, white rice, 
pasta and other foods that contain carbohydrates is preferred to limit them 
(http://www.livestrong.com/article/284378-diet-for-herpes-zoster/, accessed at 
18.06.2013).  
 
- Can the patient use/consume complementary herbs? 
 
Of course, the patient can apply local supplement in the affected skin with blisters. 
He/she can apply gel of aloe vera and the oil of vitamin E. Although the patient should 
consume herbs of Echinacea that have antiviral properties and which are found on the 
market and in tea form. In addition, a plant, which can calm the affected nerves and is 
sedative, is the passion flower (http://www.livestrong.com/article/284378-diet-for-herpes-
zoster/, accessed at 18.06.2013).  
14. Home remedies for herpes zoster 
 
General, almost no one can avoid shingles, even though avoid to contact with 
someone which have active herpes or chickenpox, sometime will have because of his own 
varicella zoster virus. Someone with shingles if come in contact with others can transmit 
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the virus to them. For this reason is an important patient with herpes to stay isolated at 
home for 7-9 days till the blisters gain crust.  
 
Also must avoid come in contact with pregnant women, people older than 50 years old 
because have weak immune system and with immunosuppressed patients such as those 
with HIV, AIDs and with organ transplantations. It is good patients with herpes to put on 
the blisters cool and wet compresses for at least 1 hour, 5 times daily. This will help the 
patients to reduce the feeling of pain and the itching.  
 
In addition, they can use anti-itch creams and lotions, like calamine or aveeno, in 
-
with herpes can take a bath with a normal hot water or can take an oatmeal bath in order 
to reduce the pain of the shingles. Except the oatmeal bath, someone can just put over the 
shingles oatmeal, which will not be cooked, with a little quantity of water. Therefore, this 
will create something like paste. Moreover, it is better to wear baggy clothes so to avoid 
the pain that caused from the friction of the blisters with the clothes. Finally, patients must 
keep the blisters clean, dry and cover then with a non-sticky bandage 
(http://www.specialityclinic.com/Herpes_Z.aspx, accessed at 05.07.2013).  
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Conclusion 
Herpes virus also known as Herpes virus 1 belongs to a class of virus that can cause 
the Varicella zoster virus and Herpes zoster. Herpes can appear only in those patients who 
have been infected by varicella zoster virus. After the primary infection, the virus remains 
dormant for decades in the dorsal ganglia root and can be reactivated when finding 
opportunity.  
Herpes zoster is a dermatomal disease and most often occurs at the lumbar or at the 
thoracic nerve part. The herpes virus can cause several infections in the human like herpes 
zoster or herpes genital. In the herpes are created shingles, which are itchy and are very 
dangerous when appearing in parts of the face. 
Herpes is a painful situation and the most common symptoms are the feeling of 
burning, itching, headache, fever and paresthesia. Also in this thesis are analyzed the risk 
factors that increase the appearance of herpes and are the primary infection with VZV, the 
age because the greater age one has the greater chances have to develop herpes, the 
immunosuppressant patients, certain drugs that decrease the immune system, the female 
has greater chances to develop and the white race.  
In order to avoid all the complications that cause the herpes this thesis analyzes and 
informs the patients about all the signs, the symptoms and the prognosis of herpes. Some 
of the complications are the postherpetic neuralgia, Ramsay Hunt syndrome, glaucoma, 
retinitis, hematuria and many others. 
This diploma thesis wants to emphasize that just from the first symptoms the patient 
should contact with the doctor in order to give him the proper therapy. For the treatment 
of herpes zoster can be used many drugs like antiviral drugs, analgesics, opioids, 
corticosteroids and tricyclic antidepressants. However, the drugs that are preferred more 
are the antiviral drugs, the acyclovir and the valacyclovir. In addition, this thesis analyzes 
and discloses the causes of herpes zoster and what this can causes.  
Prophylactic ways are marked for herpes especially for elderly, which are at high risk 
to develop zoster. Consequently, it is important for them to follow the right treatment 
when become infected and protect themselves from other people that are affecting of 
herpes so as not to spread the virus. Also are marked except the drugs, which can be used 
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and home remedies for patients with herpes. The diagnosis of herpes zoster usually is 
done clinically with Tzanck test, direct immunofluorescent test or immunoglobulin test. 
In this thesis is highlighted the severity of herpes and the complications that causes in 
elderly people who exceed the population of younger people. For this reason, this thesis 
wants to point that the elderly people should receive the vaccine Zostavax that is against 
herpes zoster. 
Many researches have been conducted and continue until nowadays about Herpes 
zoster. Vaccination strategies for both varicella and herpes zoster will need to evaluate 
and adjusted periodically as changes in the epidemiology of these varicella zoster virus 
diseases become more evident. 
Science is constantly evolving; many researchers are in laboratories and give daily 
struggle to find new drugs and vaccines. In such way, we will be able to avoid the most 
painless way inconveniences caused by the virus, faster and more efficiently. Everyone 
nowadays with the fast pace of life and the constant stress we want to continually improve 
the quality of life. For this reason it is important the awareness and the action by all of us 
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